Your browser doesn't support javascript.
loading
Supporting the Next Generation of Scientists to Lead Cancer Immunology Research.
Alspach, Elise; Chow, Ryan D; Demehri, Shadmehr; Guerriero, Jennifer L; Gujar, Shashi; Hartmann, Felix J; Helmink, Beth A; Hudson, William H; Ho, Won Jin; Ma, Leyuan; Maier, Barbara B; Maltez, Vivien I; Miller, Brian C; Moran, Amy E; Parry, Erin M; Pillai, Padmini S; Rafiq, Sarwish; Reina-Campos, Miguel; Rosato, Pamela C; Rudqvist, Nils-Petter; Ruhland, Megan K; Sagiv-Barfi, Idit; Sahu, Avinash Das; Samstein, Robert M; Schürch, Christian M; Sen, Debattama R; Thommen, Daniela S; Wolf, Yochai; Zappasodi, Roberta.
Afiliación
  • Alspach E; Department of Molecular Microbiology and Immunology, Saint Louis University, St. Louis, Missouri.
  • Chow RD; Department of Genetics, Yale University School of Medicine, New Haven, Connecticut.
  • Demehri S; Center for Cancer Immunology and Cutaneous Biology Research Center, Department of Dermatology, Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. SDEMEHRI1@mgh.harvard.edu.
  • Guerriero JL; Department of Surgery, Division of Breast Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
  • Gujar S; Department of Pathology, Microbiology and Immunology, and Biology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Hartmann FJ; Department of Pathology, School of Medicine, Stanford University, Palo Alto, California.
  • Helmink BA; Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.
  • Hudson WH; Emory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia.
  • Ho WJ; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Ma L; Koch Institute for Integrative Cancer Research and Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts.
  • Maier BB; CeMM-Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Maltez VI; Lymphocyte Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda; National Institute of General Medical Sciences, National Institutes of Health, Bethesda, Maryland.
  • Miller BC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston; Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston; Broad Institute of Harvard and Massachus
  • Moran AE; Department of Cell, Developmental and Cancer Biology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.
  • Parry EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston; Harvard Medical School, Boston, Massachusetts.
  • Pillai PS; Koch Institute for Integrative Cancer Research and Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts.
  • Rafiq S; Winship Cancer Institute and Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia.
  • Reina-Campos M; Division of Biological Sciences, Section of Molecular Biology, University of California, San Diego, La Jolla, California.
  • Rosato PC; Department of Microbiology and Immunology, The Geisel School of Medicine at Dartmouth College, Lebanon, New Hampshire.
  • Rudqvist NP; Department of Thoracic/Head and Neck Medical Oncology and Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ruhland MK; Department of Cell, Developmental and Cancer Biology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.
  • Sagiv-Barfi I; Division of Oncology, Department of Medicine, Stanford University, Stanford, California.
  • Sahu AD; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Samstein RM; Department of Radiation Oncology, Precision Immunology Institute, Icahn School of Medicine at Mount Sinai Hospital, New York, New York.
  • Schürch CM; Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany.
  • Sen DR; Department of Medicine and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Thommen DS; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Wolf Y; Evergrande Center for Immunologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Zappasodi R; Weill Cornell Medicine, Weill Cornell Medical College, New York; Parker Institute for Cancer Immunotherapy; Memorial Sloan Kettering Cancer Center, New York, New York.
Cancer Immunol Res ; 9(11): 1245-1251, 2021 11.
Article en En | MEDLINE | ID: mdl-34544686
Recent success in the use of immunotherapy for a broad range of cancers has propelled the field of cancer immunology to the forefront of cancer research. As more and more young investigators join the community of cancer immunologists, the Arthur L. Irving Family Foundation Cancer Immunology Symposium provided a platform to bring this expanding and vibrant community together and support the development of the future leaders in the field. This commentary outlines the lessons that emerged from the inaugural symposium highlighting the areas of scientific and career development that are essential for professional growth in the field of cancer immunology and beyond. Leading scientists and clinicians in the field provided their experience on the topics of scientific trajectory, career trajectory, publishing, fundraising, leadership, mentoring, and collaboration. Herein, we provide a conceptual and practical framework for career development to the broader scientific community.
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Médicos / Investigación Biomédica / Alergia e Inmunología / Neoplasias Límite: Humans Idioma: En Revista: Cancer Immunol Res Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Médicos / Investigación Biomédica / Alergia e Inmunología / Neoplasias Límite: Humans Idioma: En Revista: Cancer Immunol Res Año: 2021 Tipo del documento: Article